Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 2;16(1):33.
doi: 10.1186/s13102-024-00817-5.

Effects of a randomized-controlled and online-supported physical activity intervention on exercise capacity, fatigue and health related quality of life in patients with post-COVID-19 syndrome

Affiliations

Effects of a randomized-controlled and online-supported physical activity intervention on exercise capacity, fatigue and health related quality of life in patients with post-COVID-19 syndrome

Arno Kerling et al. BMC Sports Sci Med Rehabil. .

Abstract

Background: The Post-COVID-19 syndrome (PCS), which can occur after acute respiratory syndrome coronavirus 2 infection, leads to restrictions in everyday activity. Our study assessed the impact of an online-guided intervention which intended to facilitate physical activity on the mental and physical capability of PCS patients.

Methods: We randomized 62 patients with PCS (20 male/ 42 female; age: 46 ± 12 years; body mass index: 28.7 ± 6.7 kg/m2) with a score ≥ 22 in the fatigue assessment scale (FAS) to a 3-month exercise-focused intervention (IG n = 30) or control period (CG n = 32). We assessed changes in exercise capacity (bicycle exercise test with measurements of gas exchange), fatigue, markers of health-related quality of life (HrQoL) and mental health.

Results: The FAS score decreased significantly in both study groups (IG: 35.1 ± 7.4 to 31.8 ± 8.5 points; CG: 35.6 ± 7.4 to 32.6 ± 7.5 points, both p < 0.01). Exercise capacity did not increase in the CG or IG (within-group changes for IG: peak oxygen uptake: 0.9 ± 2.6 ml/min/kg, p = 0.098; peak power output: 6.1 ± 17.8 W, p = 0.076) with no significant changes in HrQoL and work ability. Patients with a FAS score at baseline ≥ 35 (severe fatigue) showed no change in exercise capacity with the 3-month intervention whereas the sub-group of patients with FAS < 35 points (moderate fatigue) showed improvements, independent of the study group.

Conclusions: Our 3-month intervention seems appropriate for patients with moderate fatigue, whereas those with more severe fatigue appear to be too restricted with respect to their mental or physical health status to perform exercise at a level which is sufficient to improve markers of physical performance.

Trial registration: German Clinical Trials Register (registration trial number: DRKS00026245) on September 2 2021.

Keywords: Exercise; Mental health; Physical performance; SARS-CoV-2; Telerehabilitation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Patient flow during the study. COVID-19: Coronavirus disease 2019
Fig. 2
Fig. 2
Effects of the 3-month study on fatigue (A), exercise capacity (B) and depression severity (C) of the intervention group (n = 30) and the control group (n = 32). Data were mean (SEM). *Significant difference between baseline and after intervention within-group as analysed with a Student´s T-Test for paired samples. The framed p-value gives the significance level for the difference between groups over time as assessed with an analysis of covariance adjusted for age, sex and the respective baseline value of the tested parameter
Fig. 3
Fig. 3
Effects of the 3-month intervention on peak oxygen uptake (V̇O2peak) for patients in the intervention (n = 30) and control (n = 32) groups assembled into those with a fatigue assessment scale (FAS) score below and above 35 points. *p < 0.05 for the delta V̇O2peak (change of V̇O2peak) within the specific sub-group as analysed with a Student´s T-Test for paired samples. Data were mean (SEM)

References

    1. Soriano JB, Murthy S, Marshall JC, et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102–e7. doi: 10.1016/S1473-3099(21)00703-9. - DOI - PMC - PubMed
    1. Townsend L, Dowds J, O’Brien K, et al. Persistent poor health after COVID-19 is not associated with respiratory complications or initial disease severity. Annals of the American Thoracic Society. 2021;18:997–1003. doi: 10.1513/AnnalsATS.202009-1175OC. - DOI - PMC - PubMed
    1. Malkova A, Kudryavtsev I, Starshinova A, et al. Post COVID-19 syndrome in patients with asymptomatic/mild form. Pathogens (Basel Switzerland) 2021;10:10111408. - PMC - PubMed
    1. German Medical Association. Statement on „Post-COVID-Syndrom (PCS) 2022. [https://www.bundesaerztekammer.de/fileadmin/user_upload/BAEK/Themen/Medi... Accessed: Dec 28 2023.
    1. Conceicao C, Thakur N, Human S, et al. The SARS-CoV-2 spike protein has a broad tropism for mammalian ACE2 proteins. PLoS Biol. 2020;18:e3001016. doi: 10.1371/journal.pbio.3001016. - DOI - PMC - PubMed